{
    "nct_id": "NCT05877144",
    "official_title": "Preservation of Erectile Function With Early Postoperative Application of Low Intensity Shockwave Therapy After Nerve Sparing Radical Prostatectomy",
    "inclusion_criteria": "* Provide signed and dated informed consent form\n* Willing to comply with all study procedures and be available for the duration of the study\n* Men aged 18-80 diagnosed with localized prostate cancer\n* Score 12 or higher on the pre-operative International Index of Erectile Function (IIEF) assessment\n* Undergo the nerve-sparing radical prostatectomy procedure\n* Be taking PDE5i medication for the entirety of the study (normal course of care)\n* Be in a sexual relationship with a partner for at least 3 months\n* Be willing to attempt sexual activity during the screening period and before each follow-up visit\n* Be willing to stop all erectile aids (e.g. prescription and non-prescription erectile medications not part of this study, penile injections, vacuum erection devices, constriction rings) during the screening and study period\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* â€¢ Subject does not speak or understand English\n\n  * Subject has been treated with acoustic wave previously\n  * Subject has had prior penile surgery\n  * Patients with pacemakers or implantable defibrillators\n  * Patients who are using devices which are sensitive to electromagnetic radiation\n  * Patients who are found to have metastatic disease and require radiation/hormone therapy before initiation of shockwave/sham treatments\n  * Subject has lesions or active infections on the penis or perineum\n  * Subject is unwilling to remove piercings from the genital region\n  * Subject has a history of substance abuse within 12 months prior, or consuming > 14 alcoholic drinks per week\n  * Subject has received an investigational drug within 30 days prior to signing consent\n  * Subject has received platelet-rich plasma (PRP) within 3 months of signing consent\n  * Subject has received stem cell within 6 months of signing consent\n  * Subject has any condition or exhibits behavior that indicates to the principle investigator (PI) that the subject is unlikely to be compliant with study procedures and visits\n  * Cognitively/decisionally-impaired individuals",
    "miscellaneous_criteria": ""
}